Noteworthy Wednesday Option Activity: TROW, UNH, ISRG

UnitedHealth (UNH) saw unusually large options activity with 62,768 contracts traded (~6.3 million underlying shares), equal to roughly 52.9% of its 11.9 million average daily share volume; the $285 call expiring Feb 6, 2026 accounted for 2,270 contracts (~227,000 shares). Intuitive Surgical (ISRG) saw 10,873 contracts (~1.1 million underlying shares), about 48.4% of its 2.2 million average daily volume, led by 1,900 contracts (~190,000 shares) in the $500 put expiring May 15, 2026. These flows represent significant single-day options interest and could reflect concentrated directional bets or hedging activity with potential to influence near-term intraday price action in both large-cap healthcare names.

Analysis

Market structure: The heavy flow — UNH Feb 6, 2026 285 calls (2,270 contracts ≈227k shares) and ISRG May 15, 2026 500 puts (1,900 contracts ≈190k shares) — is large relative to ADTV (UNH ~53%, ISRG ~48%) and implies institutional directional positions or large hedges. Call buying on UNH signals bullish positioning or takeover/earnings convexity bets; large ISRG put blocks signal either outright bearish conviction or insurance against device/regulatory risk. Delta-hedging from market-makers on these block trades can create tangible near-term flow into/out of the underlying as IV and price move toward strikes (especially in the 1–6 month window).

Risk assessment: Key tail risks are regulatory (CMS MA policy changes over next 60–120 days), device recalls/litigation for ISRG, and option gamma squeezes around option expiries (Feb and May 2026). Immediate (days–weeks) risk is flow-driven volatility from delta-hedging; short-term (1–6 months) risk centers on CMS announcements and company earnings; long-term fundamentals hinge on demographic trends and pricing power for payers vs procedure volumes for med-tech. Hidden dependency: the trades may be part of structured or volatility-selling programs (not pure directional bets) — if they are hedges, price moves could reverse when hedges unwind.

Trade implications: Prefer defined-risk option structures: for UNH, a bullish calendar/vertical that captures upside while limiting premium; for ISRG, a defined put spread to express downside without open tail exposure. Consider relative-value: long UNH (payer, lower operational event risk) vs short ISRG (procedure-sensitive med-tech) to play safety/earnings dispersion into next 3–6 months. Cross-asset: expect slight widening in senior unsecured spreads for med-tech names on negative ISRG flow and potential short-term re-pricing in healthcare credit; equity hedges (index puts) are prudent if gamma-driven moves exceed 5–10% intraday.

Contrarian angles: The visible put flow into ISRG may be cheap downside protection bought by long-term holders rather than a signal of imminent collapse — if so, IV could be overstated and selling premium (put spreads) might be rewarded after no adverse news. Conversely, large UNH call buying could be takeover speculation or volatility arbitrage; if it’s hedging for other products, UNH stock may not sustain a rally once hedges unwind. Historical parallels: concentrated option blocks in 1–6 months have produced >8% moves as hedges rebalanced; be ready to fade knee-jerk moves once liquidity providers complete re-hedging.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in UNH using a defined-cost call spread: buy Feb 06 2026 285C and sell Feb 06 2026 325C (or nearest liquid strikes) to cap premium while participating in upside; size for 1–2% portfolio risk and trim half on a +8–12% move or if UNH underperforms peers for two consecutive quarters.
• Open a defensive bearish position on ISRG sized 0.5–1.0% of portfolio via a May 15 2026 500/380 put spread (buy 500P, sell 380P) to limit downside cost; widen or convert to short equity only if catalyst (FDA advisory or negative safety data) occurs within 30 days.
• Implement a relative-value pair: long UNH 1% vs short ISRG 0.75% (equity) to express payer resilience versus procedure-sensitive med-tech into CMS announcements and earnings over the next 3–6 months; rebalance if spread moves >10% in either direction.
• Monitor two binary catalysts and act: (1) CMS Medicare Advantage rate guidance expected within 60–120 days — if cuts >1% consensus, reduce UNH long by 50%; (2) any ISRG safety/recall headline within 30 days — increase downside protection to 2% portfolio or convert to outright short.